Curated coverage for dogs with top developments, timeline context, and connected threads.
The Dog Aging Project's rapamycin trial results are in. Here is what they show and why they change the landscape of human longevity research.
EuroBulletin24 Editorial Desk | Linked source
The Dog Aging Project's rapamycin trial is expected to report results in 2026. Here is why this experiment matters for human longevity science and what it could change.
Scientists are studying how to help dogs live longer, healthier lives. The research insights are also reshaping human aging science. Here is what they have found so far.